A shorter hospital stay can affect medical spending, but the length of stay and the patient’s bill are different outcomes. One study examined a lower-spine operation. People with a prior semaglutide prescription had shorter stays and lower costs [1].
What did researchers find after lumbar fusion?
Researchers compared 425 patients with active semaglutide prescriptions with 2,514 matched controls undergoing anterior lumbar interbody fusion. The stay was 0.6 days shorter on average. Same-day surgical costs were about $10,400 lower, and 90-day postoperative costs were about $9,700 lower. The study did not detect statistically clear differences in the measured complications at 90 days or two years [1].
Our breakdown of the lumbar fusion costs separates charges on the day of surgery from those in follow-up. The study used claims records. Patient selection or unmeasured surgical complexity could account for the differences. The study does not explain why costs differed.
How did other operations compare?
Our review of trigger finger studies looks at treatment and recovery after a different procedure. The studies below describe major operations and hospital outcomes.
Our review of a separate hip fracture registry examines complications and readmissions. Those outcomes answer different questions from the length of the initial hospital stay.
A posterior cervical spine study matched 1,719 people without diabetes who used a GLP-1 drug with 1,719 who did not. Within 90 days, the odds ratio for an emergency department visit was 0.71 (95% CI 0.58 to 0.87). The odds ratio for hospital admission was 0.54 (95% CI 0.41 to 0.70) [2]. Those figures count later encounters. They do not measure the length of the initial stay.
A study of femoral neck fracture repair included adults with type 2 diabetes. Researchers matched 112 GLP-1 users with 224 nonusers. It did not detect a statistically clear difference in length of stay[3]. The studies involved different operations and patient groups, so the lumbar fusion finding cannot predict recovery after other procedures.
What should I tell my surgical team?
Tell your surgical and anesthesia teams which medicine you take and when you last took it. The decision about managing a GLP-1 before surgery depends on factors such as your procedure, symptoms and reason for taking the drug. The hospital stay studies did not test whether continuing or pausing medication changes surgical outcomes [4].